Table 1.
Laboratory Test Results of the Patient
| Test Parameter | Reference Range | On the Day of Admission | After 2 Weeks of Treatment |
|---|---|---|---|
| WBC count (×109/L) | 4–10 | 9.65 | 6.81 |
| Neutrophil count (×109/L) | 1.8–6.3 | 7.37 | 3.79 |
| Neutrophil (%) | 40–75 | 76.3 | 55.6 |
| Lymphocyte count (×109/L) | 1.1–3.2 | 1.24 | 2.14 |
| Lymphocyte (%) | 20–40 | 12.8 | 31.4 |
| CRP (mg/L) | 0–5 | 189.28 | 12.5 |
| Procalcitonin (ng/mL) | 0–0.05 | 0.09 | 0.07 |
| ALT (U/L) | 9–50 | 128 | 76.5 |
| AST (U/L) | 15–40 | 57.8 | 42.9 |
| LDH (U/L) | 109–245 | 238 | 254 |
| Creatinine (μmol/L) | 62–106 | 88.3 | 73.2 |
| CK (U/L) | 26–196 | 336 | 138 |
| CK-MB (U/L) | 0–25 | 10 | 10.3 |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; CK-MB, creatine kinase muscle isoenzyme; CRP, C-reactive protein; LDH, lactate dehydrogenase; WBC, white blood cell.